Sign up to save your podcasts
Or
Share Eli Lilly's Alzheimer's Drug Shows Greatest Benefit Yet
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Eli Lilly's Alzheimer's Drug Shows Greatest Benefit Yet
Donanemab slowed cognitive decline in people with early Alzheimer’s disease by 35%, according to the company.
View all episodes
By TIME
4.2
6666 ratings
Donanemab slowed cognitive decline in people with early Alzheimer’s disease by 35%, according to the company.
More shows like TIME
View all
Global News Podcast
7,724 Listeners
Bloomberg Businessweek
439 Listeners
6 Minute English
1,832 Listeners
Learning English Vocabulary
523 Listeners
Learning English Stories
398 Listeners
Person of The Week
150 Listeners
Learning English from the News
265 Listeners
CNN 5 Things
1,336 Listeners
聽天下：天下雜誌Podcast
190 Listeners
游庭皓的財經皓角
50 Listeners
Gooaye 股癌
754 Listeners
台灣通勤第一品牌
306 Listeners
聽故事學英文
60 Listeners
唐陽雞酒屋
338 Listeners
Learning English For Work
51 Listeners
禎甄要chat內
110 Listeners
Future Back Drinking with Dr. Athina Kanioura
10 Listeners